CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-01 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $51.06 | $1.0M | 333,226 |
| 2023-07-03 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $53.43 | $1.1M | 353,226 |
| 2023-06-22 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $51.32 | $1.0M | 373,226 |
| 2023-02-28 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +17,369 | 17,369 | ||
| 2023-02-28 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +11,578 | 28,947 | ||
| 2022-03-21 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Purchase | +5,000 | $27.87 | $139K | 393,226 |
| 2022-03-18 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Purchase | +5,000 | $27.15 | $136K | 388,226 |
| 2021-11-19 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +383,226 | 383,226 |
Page 2 of 2 · 28 trades